PEGPLERANIB SODIUM Drug Record

  • PEGPLERANIB SODIUM chembl:CHEMBL3301576

    Alternate Names:

    E01AJ
    E-10030
    E-01AJ
    X01E
    PEGPLERANIB SODIUM
    X-01E
    E10030
    FOVISTA

    Drug Info:

    FDA Approval not approved
    Drug Class recombinant protein
    Drug Indications for treatment of age-related macular degeneration
    (0 More Sources)

    Publications:

  • PEGPLERANIB SODIUM   PDGFB

    Interaction Score: 5.15

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Mechanism of Interaction Platelet-derived growth factor subunit B inhibitor
    Direct Interaction yes

    PMIDs:
    None found


    Sources:
    ChemblInteractions TTD

  • PEGPLERANIB SODIUM   PDGFRA

    Interaction Score: 0.16

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name E-10030

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEGPLERANIB SODIUM   PDGFRB

    Interaction Score: 0.15

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name E-10030
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEGPLERANIB SODIUM   FLT1

    Interaction Score: 0.13

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name E-10030
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEGPLERANIB SODIUM   FLT4

    Interaction Score: 0.12

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name E-10030

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • PEGPLERANIB SODIUM   KDR

    Interaction Score: 0.08

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Novel drug target Established target
    Trial Name E-10030

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • TdgClinicalTrial: E-10030

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of age-related macular degeneration
    Drug Class recombinant protein
    FDA Approval not approved

    Publications:

  • TTD: E-10030

    • Version: 2020.06.01

    Alternate Names:
    D01GSE TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL3301576

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications:

  • ChemblInteractions: CHEMBL3301576

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: